Prudential Financial Inc Selecta Biosciences Inc Transaction History

Prudential Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.62 - $0.85 $5,332 - $7,310	8,600 Added 25.36%	42,505 $35,000
Q3 2023 Nov 13, 2023	SELL	$1.02 - $1.23 $6,732 - $8,118	-6,600 Reduced 16.29%	33,905 $35,000
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.4 $6,349 - $8,547	6,105 Added 17.75%	40,505 $45,000
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.6 $7,104 - $11,840	7,400 Added 27.41%	34,400 $0
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $11,175 - $23,352	16,680 Added 161.63%	27,000 $35,000
Q1 2022 May 13, 2022	BUY	$1.23 - $3.31 $12,693 - $34,159	10,320 New	10,320 $13,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $120,628 - $184,908	-41,740 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $140,246 - $192,838	41,740 New	41,740 $174,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.